For citations:
Gritskevich AA, Baitman TP, Mishugin SV, Popov AY, Oganyan VA, Rusakov IG, Kostin AA. Atezolizumab (Tecentriq) as first-line therapy in patients with metastatic urothelial carcinoma. Meditsinskiy sovet = Medical Council. 2022;(22):58-64. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-22-58-64